Detection of c-kit mutations in canine mast cell tumors using fluorescent polyacrylamide gel electrophoresis

Journal of Veterinary Diagnostic Investigation

Volumn 16, Issue 2, 2004, Pages 95-100

  Jones, Cameron L R ^a   Grahn, Robert A ^a   Chien, May B ^a   Lyons, Leslie A ^a   London, Cheryl A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

EID: 1642336535     PISSN: 10406387     EISSN: None     Source Type: Journal    
DOI: 10.1177/104063870401600201     Document Type: Article

References (33)

1. al-Sarraf R, Mauldin GN, Patnaik AK, Meleo KA: 1996, A prospective study of radiation therapy for the treatment of grade 2 MCTs in 32 dogs. J Vet Intern Med 10:376-378.
2. Besmer P, Murphy JE, George PC, et al.: 1986, A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature 320:415-421.
3. Bostock DE: 1986, Neoplasms of the skin and subcutaneous tissues in dogs and cats. Br Vet J 142:1-19.
4. Buttner C, Henz BM, Welker P, et al.: 1998, Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior. J Invest Dermatol 111:1227-1231.
5. Cohen D, Reif SS, Brodey RS: 1974, Epidemiological analysis of the most prevalent sites and types of canine neoplasia observed in a veterinary hospital. Cancer Res 34:2859-2868.
6. Downing S, Chien MB, Kass PH, et al.: 2002, Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit in mast cell tumors of dogs. Am J Vet Res 63:1718-1723.
7. Frimberger AE, Moore AS, LaRue SM, et al.: 1997, Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989-1993). J Am Anim Hosp Assoc 33:320-324.
8. Furitsu T, Tsujimura T, Tono T, et al.: 1993, Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand independent activation of c-kit product. J Clin Invest 92:1736-1744.
9. Galli SJ, Zsebo KM, Geissler EN: 1994, The kit ligand, stem cell factor. Adv Immunol 55:1-95.
10. London CA, Galli SJ, Yuuki T, et al.: 1999, Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit. Exp Hematol 27:689-697.
11. Longley BJ, Ma Y, Carter E, McMahon G: 2000, New approaches to therapy for mastocytosis. A case for treatment with kit kinase inhibitors. Hematol Oncol Clin North Am 14:689-695.
12. Longley BJ, Jr., Metcalfe DD, Tharp M, et al.: 1999, Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci USA 96:1609-1614.
13. Ma Y, Longley BJ, Wang X, et al.: 1999, Clustering of activating mutations in c-KIT's juxtamembrane coding region of canine mast cell neoplasms. J Invest Dermatol 112:165-170.
14. Macy DW, MacEwen EG: 1989, Mast cell tumors. In: Clinical veterinary oncology, ed. Withrow SJ, MacEwen EG, pp. 156-166. JB Lippincott, Philadelphia, PA.
15. Metcalfe DD: 1991, Classification and diagnosis of mastocytosis: current status. J Invest Dermatol 96:2S-4S.
16. Metcalfe DD, Akin C: 2001, Mastocytosis: molecular mechanisms and clinical disease heterogeneity. Leuk Res 25:577-582.
17. Nagata H, Okada T, Worobec AS, et al.: 1997, c-kit mutation in a population of patients with mastocytosis. Int Arch Allergy Immunol 113:184-186.
18. Nocka K, Buck J, Levi E, Besmer P: 1990, Candidate ligand for the c-kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors. EMBO J 10:3287-3294.
19. Patnaik AK, Ehler WJ, MacEwen EG: 1984, Canine cutaneous mast cell tumors: morphologic grading and survival time in 83 dogs. Vet Pathol 21:469-474.
20. Priester WA: 1973, Skin tumors in domestic animals. Data from 21 US and Canadian colleges of veterinary medicine. J Natl Cancer Inst 50:457-466.
21. Seguin B, Leibman NF, Bregazzi VS, et al.: 2001, Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999). J Am Vet Med Assoc 218: 1120-1123.
22. Simoes JP, Schoning P, Butine M: 1994, Prognosis of canine mast cell tumors: a comparison of three methods. Vet Pathol 31: 637-647.
23. Toonen RJ, Hughes S: 2001, Increased throughput for fragment analysis on an ABI PRISM 377 automated sequencer using a membrane comb and STRand software. Biotechniques 31:1320-1324.
24. Travis WD, Li C-Y: 1993, Mast cell diseases. In: The mast cell in health and disease, ed. Kaliner MA, Metcalfe DD, pp. 723-741. Marcel Dekker Inc, New York, NY.
25. Tsujimura T, Furitsu T, Morimoto M, et al.: 1994, Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P815 generated by a point mutation. Blood 83:2619-2626.
26. Tsujimura T, Furitsu T, Morimoto M, et al.: 1995, Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3. Int Arch Allergy Immunol 106:377-385.
27. Tsujimura T, Morimoto M, Hashimoto K, et al.: 1996, Constitutive activation of c-kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids at the juxtamembrane domain. Blood 87:273-283.
28. Worobec AS, Semere T, Nagata H, Metcalfe DD: 1998, Clinical correlates of the presence of the Asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis. Cancer 83:2120-2129.
29. Yarden Y, Kuang WJ, Yang-Fong T, et al.: 1987, Human protooncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341-3351.
30. Zemke D, Yamini B, Yuzbasiyan-Gurkan V: 2001, Characterization of an undifferentiated malignancy as a mast cell tumor using mutation analysis in the proto-oncogene c-KIT. J Vet Diagn Invest 13:341-345.
31. Zemke D, Yamini B, Yuzbasiyan-Gurkan V: 2002, Mutations in the juxtamembrane domain of c-KIT are associated with higher grade mast cell tumors in dogs. Vet Pathol 39:529-535.
32. Zsebo KM, Williams DA, Geissler EN, et al.: 1990, Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 633:213-224.
33. Zsebo KM, Wypych J, McNiece IK, et al.: 1990, Identification, purification, and biological characterization of hematopoeitic stem cell factor from buffalo rat liver-conditioned medium. Cell 63:195-201.